Katz R

No ORCID on file · 6 papers in corpus · active 2014-2025
2025
Health equity ·doi:10.1177/24731242251365480

ObjectivesBlack patients have the highest mortality rate from endometrial cancer (EC), and yet remain underrepresented in EC research. Thus, currently published symptom patterns may not be comprehensive for this population. The purpose of t…

2025
Gynecologic oncology reports ·doi:10.1016/j.gore.2025.101922

ObjectiveBlack patients with endometrial cancer (EC) experience disproportionately advanced stage at diagnosis. We aimed to identify variables, beyond race and histologic subtype, which increase risk for delayed diagnosis of EC.MethodsThis …

2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.07.690

BackgroundIndividuals with germline BRCA1 and BRCA2 pathogenic variants (BRCA carriers) are at high risk of developing high grade serous ovarian carcinoma (HGSC). HGSC is predominantly driven by TP53 mutations, but mutations in this gene ar…

2023
Journal of women's health (2002) ·doi:10.1089/jwh.2022.0534

Background: Provider uncertainty about the appropriate guideline-concordant evaluation of endometrial cancer (EC) symptoms may be a factor in racial inequities in EC. To evaluate the relationship between EC knowledge and reported practice p…

2022
Cancer research communications ·doi:10.1158/2767-9764.crc-22-0314

Current screening methods for ovarian cancer (OC) have failed to demonstrate a significant reduction in mortality. Uterine lavage combined with TP53 ultra-deep sequencing for the detection of disseminated OC cells has emerged as a promising…

2014
Research and reports in urology ·doi:10.2147/rru.s66861

BackgroundPartial cystectomy provides oncological results comparable with those of radical cystectomy in selected patients with invasive bladder cancer without the morbidity associated with radical cystectomy and urinary diversion. We descr…